Trailing Twelve Months Sales Growth: Pfizer Corp (PFE)

Public company logo of Pfizer Corp (PFE)

Geopolitical risks and patent disputes may limit the global expansion of Pfizer Inc. (PFE). The rolling year-over-year commercial revenue trend captures these fluctuations, where the value of 1.30 characterizes this level. Growth prospects rely on oncology developments and synergy with Seagen, while the optimization of third-party contractor management is designed to significantly reduce the behemoth's operating expenses.

PFE: Pfizer Corporation Sales Growth YoY (TTM) 02/11/2024 - 11/15/2026

Pfizer Corp (PFE) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Rate Chart Pfizer Corp|PFE - Price Target Chart
- company stock exchange capitalization indicators:
Market Valuation Pfizer Inc.|PFE - Enterprise Value
- book capitalization indicators:
Share Book Value Pfizer|PFE - Book Capitalization|Market Capitalization to Book Value pfizer.com|PFE - Cumulative Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Equity Pfizer Inc.|PFE - Long-Term Debt to Capital|Current Liabilities to Capital Pfizer Inc|PFE - Company Debts|Debt to Net Assets Ratio Pfizer Corporation|PFE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Pfizer|Interim Coverage Ratio pfizer.com
- earnings and valuation multiples information:
PFE - Company Net Income|Net Profit Forecast Pfizer Inc.|PFE - P/E Multiple|Projected Price to Earnings Pfizer|PFE - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Pfizer Inc|PFE - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Pfizer|PFE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share trend for the last twelve months pfizer.com|PFE - Earnings growth in current year|Expected net earnings per share growth next year Pfizer Inc.
- sales revenue and business income indicators:
PFE - Company Revenue|Company Expected Revenue Pfizer Corporation|PFE - P/S Multiple|Forward Price to Sales Pfizer Inc.|PFE - Sales Growth YoY (TTM)
Analysis of all company metrics:Pfizer Inc.
Finished products of Pfizer Corporation

Investors utilize fundamental metrics to distinguish short-term volatility from sustainable business development trends. This indicator measures the percentage change in revenue over a rolling year, and the current value of 1.30 for the rolling annual growth in sales revenue reflects the effectiveness of Pfizer Inc. (PFE) production modernization and the transition to "green chemistry" as part of its carbon neutrality strategy.

Competitor analysis for Pfizer Inc.

Revenue Growth Rate YoY (Last Twelve Months) Eli Lilly & Co.|AbbVie Corp. - Sales Growth YoY (TTM)|AZN - Sales Growth YoY (TTM)|Novartis Pharma (NVS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Merck & Co. (MRK)|Revenue Growth YoY (Last 12 Months) NVO|Revenue Growth YoY (Last 12 Months) Amgen Corporation (AMGN)|Sales Growth YoY (Last Twelve Months) Sanofi SA (SNY)|Annual Revenue Growth (Last Twelve Months) Bristol Myers Squibb|Sales Growth YoY (Last Twelve Months) GlaxoSmithKline plc GSK|TAK: Sales Growth YoY (Last 12 Months)|TEVA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Dr. Reddy's Lab|VTRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) ROIV|ZLAB (Zai Lab) - Sales Growth YoY (TTM)|BHC: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) COSM